Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03248557 : Prognostic Value of Ventricular Fibrillation Spectral Analysis in Sudden Cardiac Death
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- In or out-of-hospital cardiac arrest with ventricular fibrillation (VF) as first
documented rhythm.

- A ?3-second VF tracings before the first direct current (DC) shock.

- Signed informed consent. Patients unable to consent, it will be requested to an
authorized relative.

- Study group: GCS ?8 and subject to temperature management (hypothermia 32-34ºC or
normothermia 36ºC).

- Control group: GCS=15, thus no indication for temperature management.

Exclusion Criteria:

- First documented rhythm other than VF (e.g. ventricular tachycardia, pulseless
electrical activity, asystole)

- Unavailable or suboptimal quality of the ECG tracing before the first DC shock.

- Terminal disease or cognitive impairment before the SCD event.

- Other possible causes of comatose status different from SCD (e.g. drugs, traumatic
brain injury, hypoxia).

- Aged under 18 .

- Unwilling to provide the informed consent.

- Comatose status (GCS?8) and absence of temperature management or GCS ?9 if temperature
management was undertaken.

- Hemodynamic instability leading to incomplete 24 h of temperature management

- Early mortality and absence of subsequent withdrawal of sedation to assess cerebral
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557